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Heterotopic caesarean scar pregnancy (CSP) is a coexistence of an intrauterine pregnancy with an ectopic pregnancy 
located in a caesarean scar. The are no universal treatment guidelines to manage this extremely rare condition. Vaginal 
bleeding is the most common symptom of heterotopic CSP, but most of the cases are asymptomatic. The management 
of heterotopic CSP is difficult especially in patients who want to preserve the intrauterine pregnancy. A 33-years-old 
patient, one caesarean section (CS) in history, at 6 weeks of gestation was admitted to the hospital to confirm the 
diagnosis of ectopic pregnancy. On transvaginal ultrasound a heterotopic pregnancy was visualized. One gestational 
sac (GS) was located within the uterus cavity, another one was implanted in the anterior wall of cervicoisthmic area in 
the caesarean scar (Fig. 1). In both embryos the foetal heart rate was observed, the crown-rump length was 3.4 mm in 
the intrauterine pregnancy and 2.4 mm in the heterotopic CSP. The cervical canal was closed and measured 49 mm in 
length. There was no bleeding on the speculum examination. The patient was asymptomatic. Several treatment options 
were described in the literature: embryo aspiration of CSP, systemic or local injection of methotrexate, local injections of 
potassium chloride (KCl) or hyperosmolar glucose, laparoscopy or hysteroscopy. After being informed about the high 
risk of continuing the heterotopic CSP and possible complications of treatment, the patient decided to preserve the 
intrauterine pregnancy (IUP) and terminate the heterotopic CSP. Selective embryo termination was performed at 7 weeks 
of gestation by local ultrasound guided injection of KCl into the GS implanted in the caesarean scar. After the procedure 
the foetal heart rate was no longer visible in the heterotopic CSP, but confirmed in the IUP. Further pregnancy course 
was normal (Fig. 2) and there were no ultrasound abnormalities in the caesarean scar area (Fig. 3). The patient delivered 
a 3060g healthy male infant by elective CS at 37 weeks of gestation. The procedure and the puerperium were not com-
plicated. During the CS only a minimal dehiscent was seen in the previous caesarean scar area (Fig. 4). Heterotopic CSP 
should be considered in patients with a CS in history, especially in cases where assisted reproductive technologies were 
used. Early diagnosis is the essential part of heterotopic CSP treatment. Transvaginal ultrasonography seems to be the 
ideal tool to detect heterotopic CSP in the 1st trimester. Early detection and treatment of heterotopic CSP increases the 
probability of preserving the IUP.  
Figure 1. Transvaginal 
ultrasonographic images of 
IUP (A) and ectopic CSP (B) at 6 
weeks of gestation
Figure 2. Transvaginal 
ultrasonographic image of 
preserve foetus (A) at 9 weeks of 
gestation. The heterotopic CSP is 
still visible (B)
Figure 3. A normal caesarean scar 
(arrow) was seen at 33 weeks of 
gestation during an ultrasound 
examination
Figure 4. A minimal dehiscent 
(arrow) was seen during the 
caesarean section performed at 
37 weeks of gestation
